4//SEC Filing
Yarema Kristin 4
Accession 0001209191-20-010848
CIK 0001604464other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 8:53 PM ET
Size
5.5 KB
Accession
0001209191-20-010848
Insider Transaction Report
Form 4
Yarema Kristin
Chief Commercial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2020-02-18+110,000→ 110,000 totalExercise: $14.56Exp: 2030-02-17→ Common Stock (110,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on February 18, 2021 and the remaining shares vest in equal monthly installments over the following 36 months.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001803794
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 8:53 PM ET
- Size
- 5.5 KB